50 likes | 64 Views
Suppl Fig 1. Heidelberg 2005-2013: Chronic GVHD over time in all patients available for GVL response pattern analysis (n=60, -> excluding patients with non-engraftment, death <120d, or rel <120d). Suppl Fig 2. Impact of start of IS taper on outcome. REL. NRM. Suppl Fig 3.
E N D
Suppl Fig 1 Heidelberg 2005-2013:Chronic GVHD over time in all patients available for GVL response pattern analysis (n=60, -> excluding patients with non-engraftment, death <120d, or rel <120d)
Suppl Fig 2 Impact of start of IS taper on outcome REL NRM
Suppl Fig 3 Impact of status on outcome REL NRM PFS OS
Suppl Fig 4 Impact of conditioning on outcome REL NRM PFS OS
Suppl Fig 5 Impact of EBMT risk on outcome NRM REL PFS OS n.s.